mRNA-1273
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for mRNA-1273, covering 2022-12-30 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) [Phase 4]